
Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement

Hal Walsh currently serves as the Chief Executive Officer of SymmetryRx, LLC.
As CEO, Hal provides vision, strategy, leadership, and resources to build web-based solutions to increase the reach of pharmaceutical manufacturers to healthcare providers and their patients.
Articles by Hal Walsh, Brand Insights Contributor, CEO of SymmetryRx, LLC
Advertisement
Latest Updated Articles
Prescriber Access to Drug Samples in Virtual EnvironmentsPublished: March 15th 2021 | Updated:
The NRx CrisisPublished: November 19th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Amazon Pharmacy Adds FDA-Approved Wegovy Pill, the First Oral GLP-1 for Weight Loss
2
Why US-Based Manufacturing Is Becoming a Strategic Imperative for Biopharma
3
Pharma Pulse: J&J Enters TrumpRx and the Red Flags in Pediatric Vaccines
4
Pharma Pulse: Amazon Pharmacy Sells Oral Wegovy, J&J’s Billion-Dollar Hub, and the Debt-Housing Crisis
5